Funds · AGLE

Who owns AGLE?

No institutional manager reported a Aeglea BioTherapeutics Inc. position in the latest Form 13F data we have. 13F covers US-listed shares held by managers with at least $100 million in such securities.

AGLE news and filings · Top funds